03 July 2021 : Clinical Research
Factors Associated with the Prognosis of Patients with Acute Myocardial Infarction and Cardiogenic Shock
Ke-Fu Feng1ABCDEF, Min Wu2BC, Li-Kun Ma1ADE*DOI: 10.12659/MSM.929996
Med Sci Monit 2021; 27:e929996
Table 4 Adverse events in the 2 groups.
| Adverse events | Survival group (n=92) | Non-survival group (n=49) | P |
|---|---|---|---|
| No-reflow during surgery | 13 (14.1%) | 24 (49.0%) | <0.01 |
| Malignant arrhythmia | 4 (4.3%) | 3 (6.1%) | 0.644 |
| Stent thrombosis | 0 (0.0%) | 1 (2.0%) | 0.348 |
| Stroke | 1 (1.1%) | 0 (0.0%) | 0.652 |
| Bleeding | 3 (3.3%) | 2 (4.1%) | 0.570 |






